GlassScriptPhysician profile
Christopher W Glanton
NPI 1609840222
$38,597.12
in general payments reported to CMS, 2019-2025
17 companies · $15.33 in 2025
The $15.33 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $14K · 2021: $2,692 · 2022: $12.85 · 2023: $207 · 2025: $15.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $170 · Food and Beverage: $51.46 · Education: $1.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $170.23 |
| Food and Beverage | $51.46 |
| Education | $1.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $37,285.60 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $211.58 | 2019-2021 | |
| Mission Medical Distribution, LLC | $182.36 | 2023 | |
| Horizon Therapeutics Plc | $164.60 | 2019-2021 | |
| Daiichi Sankyo INC. | $151.79 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $137.91 | 2021 | |
| Opko Pharmaceuticals, LLC | $89.41 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $87.11 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.73 | 2021 | |
| Aurinia Pharma U.S., INC. | $52.24 | 2021 | |
| Travere Therapeutics, INC. | $35.80 | 2019-2023 | Thiola |
| Alexion Pharmaceuticals, INC. | $32.95 | 2019-2020 | |
| Akebia Therapeutics INC | $30.19 | 2019-2021 | |
| Vifor Pharma, INC. | $29.25 | 2020 | |
| Arthrex, INC. | $24.00 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $15.33 | 2025 | |
| Amicus Therapeutics, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Glanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.